Načítá se...
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo
There is a paucity of efficacious new compounds to treat neuropsychiatric disorders. We present a novel approach to neuropsychiatric drug discovery based on high-content characterization of druggable signaling network responses at the single-cell level in patient-derived lymphocytes ex vivo. Primary...
Uloženo v:
Vydáno v: | Sci Adv |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
American Association for the Advancement of Science
2019
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6506238/ https://ncbi.nlm.nih.gov/pubmed/31086815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aau9093 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|